Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(2)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed2

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00198055Phase 2Completed
A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.
Asperger's DisorderPervasive Developmental Disorder
Principalinvestigator
NCT00870727Phase 3Completed
Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders
Pervasive Developmental Disorder
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Indiana University

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Carol M Schall, PhD

Virginia Commonwealth University

Moderately Similar
2 trials

Shared therapeutic areas:

Asperger SyndromePervasive Developmental Disorder
Similarity Score30%

Christopher Walsh, MD, PhD

Boston Children's Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Asperger SyndromePervasive Developmental Disorder

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score30%

Jean A Frazier, MD

Cambridge Health Alliance

Moderately Similar
3 trials

Shared therapeutic areas:

Asperger SyndromePervasive Developmental Disorder

Worked with same sponsors:

Bristol-Myers Squibb
Similarity Score30%

Shaun M Eack, Ph.D.

University of Pittsburgh

Moderately Similar
2 trials

Shared therapeutic areas:

Asperger SyndromePervasive Developmental Disorder

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score30%

Denis Sukhodolsky, Ph.D.

Yale University

Moderately Similar
3 trials

Shared therapeutic areas:

Asperger SyndromePervasive Developmental Disorder
Similarity Score30%

Peter G Enticott, BAppSc, PhD

The Alfred, Monash University

Related
1 trials

Shared therapeutic areas:

Asperger Syndrome
Similarity Score15%

Philip C Kendall, Ph.D.

Temple University

Related
2 trials

Shared therapeutic areas:

Asperger Syndrome

Worked with same sponsors:

National Institute of Mental Health (NIMH)
Similarity Score15%

Noha F. Minshawi, Ph.D.

Indiana University

Related
1 trials

Shared therapeutic areas:

Asperger Syndrome

Worked with same sponsors:

Indiana University
Similarity Score15%

Irit Orian, M.D.

Mental health unit for preschoolers, Ashdod, Israel

Related
2 trials

Shared therapeutic areas:

Pervasive Developmental Disorder
Similarity Score15%

Craig A. Erickson, M.D.

Children's Hospital Medical Center, Cincinnati

Related
3 trials

Shared therapeutic areas:

Asperger Syndrome

Worked with same sponsors:

Indiana University
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00198055Phase 2PrincipalInvestigator

A Study of Aripiprazole in Children and Adolescents With Aspergers and Pervasive Developmental Disorder.

Asperger's DisorderPervasive Developmental Disorder
Completed
NCT00870727Phase 3PrincipalInvestigator

Study of Aripiprazole in the Treatment of Pervasive Developmental Disorders

Pervasive Developmental Disorder
Completed

All 2 trials loaded